Clinical Trials Logo

Gynecology clinical trials

View clinical trials related to Gynecology.

Filter by:

NCT ID: NCT02769325 Not yet recruiting - Clinical trials for Laparoscopic Surgery

Atropine in Laparoscopic Gynaecological Surgery

ALGOS
Start date: May 2016
Phase: Phase 4
Study type: Interventional

This is a double blinded, randomised controlled trial that will compare atropine to placebo for postoperative pain in laparoscopic gynaecological surgery

NCT ID: NCT02638688 Completed - Gynecology Clinical Trials

Measurement of Fibroid Volume and 2D, 3D US

Start date: September 2012
Phase: N/A
Study type: Observational

Objective: To compare 2-dimensional and 3-dimensional ultrasound measurements with the actual myomas volume after surgical removal, to clinically test the validity and usability of 3D ultrasound technology as opposed to conventional 2D real-time ultrasound and to assess the reliability of different ultrasound methods to measure volume of uterine fibroids.

NCT ID: NCT02274441 Completed - Gynecology Clinical Trials

Activity and Quality of Care Indicators' for a Sentinel Network Creation

URGO
Start date: January 2015
Phase: N/A
Study type: Observational

There is no large-scale data in France or internationally, on the quality of care in gynecological emergencies, or the consequences of delay or misdiagnosis of women's health or on determinants of these delays or misdiagnosis. The creation of a sentinel network for gynecological emergencies could help quantify these links and test strategies to avoid the worst effects by implementing simple diagnostic tools from clinical research. The network will be designed to promote research in women's health and the emergency reception by focusing on: (i) Assessment of the quality and organization of care and professional practice for the management of gynecological emergencies. (ii) The study of severe morbidity and its determinants (iii) comparison of organizational practices and health outcomes of women over time within the same department or between services having substantially the same recruitment (iv) Comparison of organization systems gynecological emergencies departement between different high resource francophone countries (France, Switzerland, Belgium). (v) The assessment of new diagnostic strategies (sorting or diagnostic aid) or therapeutic derived from clinical research.

NCT ID: NCT01697566 Active, not recruiting - Gynecology Clinical Trials

An Endometrial Cancer Chemoprevention Study of Metformin

Start date: May 2, 2013
Phase: Phase 3
Study type: Interventional

The goal of this clinical research study is to learn about the effects of metformin and/or a program called "lifestyle intervention" on the endometrium (inner lining of the uterus) in post-menopausal women who are also obese (both are risk factors for endometrial cancer). Researchers also want to learn how insulin levels will be affected by metformin, diet and/or exercise. Metformin is designed to treat both diabetes and insulin resistance. Insulin resistance is a condition in which the body makes insulin but does not use it properly. It is often referred to as "pre-diabetes". Many people with insulin resistance have high levels of both sugar and insulin in their blood at the same time, which have been reported in patients with endometrial cancer. In this study, metformin will be compared to a placebo. A placebo is not a drug. It looks like the study drug but is not designed to treat any disease or illness. It is designed to be compared with a study drug to learn if the study drug has any real effect. Lifestyle intervention is made up of a series of in-person sessions where you meet with a coach to discuss strategies for losing weight and ways to increase physical activity. It also consists of materials designed to help you lose weight and will offer opportunities for supervised exercise.